Authors:
Mohs, RC
Doody, RS
Morris, JC
Ieni, JR
Rogers, SL
Perdomo, CA
Pratt, RD
Citation: Rc. Mohs et al., A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients, NEUROLOGY, 57(3), 2001, pp. 481-488
Authors:
Mobarak, CD
Anderson, KD
Morin, M
Beckel-Mitchener, A
Rogers, SL
Furneaux, H
King, P
Perrone-Bizzozero, NI
Citation: Cd. Mobarak et al., The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells, MOL BIOL CE, 11(9), 2000, pp. 3191-3203
Citation: Sl. Rogers et al., Long-term efficacy and safety of donepezil in the treatment of Alzheimer'sdisease: final analysis of a US multicentre open-label study, EUR NEUROPS, 10(3), 2000, pp. 195-203
Authors:
Bunnell, E
Lynn, M
Habet, K
Neumann, A
Perdomo, CA
Friedhoff, LT
Rogers, SL
Parrillo, JE
Citation: E. Bunnell et al., A lipid A analog, E5531, blocks the endotoxin response in human volunteerswith experimental endotoxemia, CRIT CARE M, 28(8), 2000, pp. 2713-2720
Citation: Mj. Mclaughlin et al., Review: A bioavailability-based rationale for controlling metal and metalloid contamination of agricultural land in Australia and New Zealand., AUST J SOIL, 38(6), 2000, pp. 1037-1086
Authors:
Neve, RL
Ivins, KJ
Tsai, KC
Rogers, SL
Perrone-Bizzozero, NI
Citation: Rl. Neve et al., cis-acting regulatory elements in the GAP-43 mRNA 3 '-untranslated region can function in trans to suppress endogenous GAP-43 gene expression, MOL BRAIN R, 65(1), 1999, pp. 52-60
Authors:
Rogers, SL
Karcher, RL
Roland, JT
Minin, AA
Steffen, W
Gelfand, VI
Citation: Sl. Rogers et al., Regulation of melanosome movement in the cell cycle by reversible association with myosin V, J CELL BIOL, 146(6), 1999, pp. 1265-1275
Authors:
Robbins, JR
McGuire, PG
Wehrle-Haller, B
Rogers, SL
Citation: Jr. Robbins et al., Diminished matrix metalloproteinase 2 (MMP-2) in ectomesenchyme-derived tissues of the Patch mutant mouse: Regulation of MMP-2 by PDGF and effects onmesenchymal cell migration, DEVELOP BIO, 212(2), 1999, pp. 255-263
Citation: Sl. Rogers et al., ARICEPT (R): a well-tolerated and clinically effective treatment for the symptoms of AD - Results from world-wide clinical trials, ALZHEIM REP, 1, 1998, pp. S13-S14